Business
The Japan Science and Technology Agency (JST) took the opportunity at Pittcon 2011 to highlight some of the emerging technologies developed through collaboration with academic institutes which are available for licencing. Details of selected technologies were open for discussion on the stand, hosted by Takuji Ohinata, Deputy Manager, IP and Licensing Group, Center for Intellectual Property Strategies, at JST in Tokyo. These included items under the categories of New Materials (eg, high water content Hydro-Gel); Sensors; Electronic Devices (eg, high performance thin
Opportunities Asia
By Heather Hobbs
With expansion a prime focus for businesses worldwide, many are looking towards fastly establishing new regions of growth, particularly in Asia, Pacific Rim countries. This section of International Labmate will especially look at the success of both Asian and European companies with established premises or business partnerships, highlighting the opportunities that exist while realising potential for other companies to move into export markets.
JST showcases technologies at Pittcon
film transistor); Micro(Nano) Fabrication (eg, gas cluster ion beam equipment); Measuring Equipment; Electron microscope (eg, phase- plate electron miocroscope) and BioTechnology (eg, novel enzymes, immunoassay kits); and other areas. JST, which licenses its own patents also helps universities promote and transfer their patents to the private sector through formulation of IP Strategies and the pursuit of patents. For further details of technologies available for licensing contact Japan Science and Technology Agency,
license@jst.go.jp
TO FIND OUT MORE CIRCLE NO. 135
SEPMAG & Apis Biotechnology look to Chinese IVD market
SEPMAG, a manufacturer of biomagnetic separation systems for the in vitro diagnostics sector, and Apis Biotechnology gave a joint presentation at the State sponsored Clinical Laboratory Provider & Blood Transfusion Equipment Expo, held on March 11th in the Xi¡¯an Greenland Pico International Convention & Exhibition Centre, Shanxi province, China.
The company was recently awarded a patent from China’s State Intellectual Property Office (SIPO), and marks the Company’s intentions to further expand revenues in China - a market still in its infancy, but forecast by analysts to expand at double digit pace over the coming years. As previously reported, SEPMAG has already commenced shipping the SEPMAG Q250ml to CapitalBio, its first client in the region, for the production of its IVD kits.
SEPMAG CEO, Josep Maria Simalso held a seminar on Apis Biotechnology’s stand, explaining how homogeneous separation techniques could help assist rapid growth amongst the Country’s newly established in vitro diagnostic companies.
“The Chinese government is keen to develop China’s own diagnostics technologies and advance the IVD market within the country. The Chinese market has tremendous growth potential and the company is on the cusp of an explosion of new developments in this field. Using our technologies they will be able to develop more consistent and reliable and safer results with reduced bead aggregation. This will undoubtedly help to facilitate the growth of China’s IVD industry and we look forward to advancing research for the betterment of healthcare in the region,” he said.
The joint presentation by Apis Biotechnology and SEPMAG was given at the conference organised by the Chinese Association for Clinical Laboratory Providers (CACLP), attended by high level life science audiences from across China. The event is sponsored by the National Association of Health Industry and Enterprise Management and the Chinese Association for Clinical Laboratory Providers. Moreover, the expo is supported by the Chinese Technical Committee of Clinical Laboratory Testing, together with the In Vitro Diagnostics Standardisation Administration of China.
TO FIND OUT MORE CIRCLE NO. 136 Analytica Vietnam surpasses expectations
The continuing growth of major conference and exhibition events in Asia can continue to give confidence to potential exporters in Europe with major events reporting strong attendances. In many cases smaller businesses on fact-finding missions are able to take advantage of established support from industry organisations which host companies in pavilions, helping to drive down costs of attendance.
Analytica Vietnam 2011, Saigon Exhibition & Convention Centre, Ho Chi Minh City (April 7-9) reports a higher than 25% increase on the number of exhibitors in pre-event statistics; this has been attributed to the growing presence of international and Vietnamese manufacturers of laboratory and analysis equipment and biotechnology companies underscoring the growing significance of these industries in the region, according to the organisers. Analytica Vietnam Conference will also promote dialog between industry and science. A workshop –Validation of Analytical Methods for FDA and EU compliance also takes into account Vietnam’s growing volume
of foreign trade with European and other countries.
"We are very pleased that so many companies are interested in analytica Vietnam and feel that it confirms our decision to establish a Vietnamese spin-off of analytica," explains Susanne Grödl, Exhibition Director for analytica in Munich. "The Vietnamese market for analysis and laboratory equipment has grown considerably during the last few years. That growth is now being reflected by a sizeable increase in the number of exhibitors." Germany will be very strongly represented, with 35 companies at this year's fair. The companies participating in the German Pavilion include industry leaders such as Binder, Brand, Eppendorf, Hellma, Julabo Labortechnik, KNF Neuberger, Netzsch and Waldner Laboreinrichtungen. The latest products and innovations also await visitors at joint exhibits representing China, France (organisers:UBIFRANCE) and Great Britain (organisers: GAMBICA) An overview of the exhibition highlights can be called up at
www.analytica-vietnam.com before the fair begins.
TO FIND OUT MORE CIRCLE NO. 138
BIA and NZBIO alliance formed
The BioIndustry Association (BIA) and NZBIO, the trade associations representing innovative bioscience companies in the UK and New Zealand, have signed a memorandum of understanding which establishes a strategic partnership between the United Kingdom and New Zealand. The agreement establishes a working alliance between the organisations which have similar goals and are dedicated to growing successful bioscience
companies.The alliance will provide a united voice for both UK and New Zealand bioscience companies and joint activities between the two organisations will assist member companies in building their international ties. Together the BIA and NZBIO will promote an exchange of views supporting each other in areas of policy advocacy and initiatives to enhance economic development between the two regions.
Nigel Gaymond, BIA Chief Executive, said: “We believe the partnership between the BIA and NZBIO will form the foundations of a community between our members, as well as offering the possibility of joint events to highlight opportunities for international collaboration.”
Bronwyn Dilley, Chief Executive of NZBIO, said: “As New Zealand’s bioscience industries rely heavily on international investment opportunities this alignment with the BIA will help bring people and businesses from both New Zealand and the United Kingdom together more regularly. NZBIO’s and the BIA’s strong relationship will help ‘unlock’ the potential of both regions.”
TO FIND OUT MORE CIRCLE NO. 137 CISILE gains ground
CISILE 2011, the 9th China Internation Scientific Instrument and Laboratory Equipment Exhibition, which will be held in the China Beijing Exhibition Centre (April 25-27), is emerging as the largest scale, professional expo in China with a focus on promoting advanced scientific instruments and technology. Last year’s event saw 580 exhibitors amongst which were foreign enterprises from America, Germany, Japan, India, Singapore, Russia, Finland, England, Italy, Netherlands, South Korea, Malaysia, Spain, Switzerland, Hong, Taiwan and others, according to the organisers, China Instrument Manufacturers Association. Covering nearly 30,000m2
, the scope of exhibits ranges from analytical and
testing instruments to precision optical instruments, lab furniture and equipment, mechanical testing and metrology products, chemicals, reagents and specialised instrumentation.
Does your company sell or wish to sell laboratory products and services to the vast economies of Asia? Are you looking for local distributors and agents to represent you? If so, why not advertise your products in our market-leading journal LabAsia.
Contact us today for more information Email:
info@intlabmate.com
To encourage self-innovation in manufacturing and improve industry standards, China Instrument Manufacturers Association will also host The CISILE 2011 Award with sub-groups hosting two other events: the 2011 China Scientific Instruments Development Annual Meeting (Instrument Analysis branch: Instrument Information Network) and the 2011 China Scientific Instruments Applied Technology Seminars (Beijing physical test and chemical analysis technology society). The former meeting will focus on the latest policies of China and the outlook for the scientific instrument industry; Principles from the Chinese provincial and municipal government departments, trade associations and professional bodies, companies and distribution agencies have been invited to attend. The Seminars will be presented by experts highlighting their latest products and also participating in discussion of trends in test and analysis applied technology.
Further details can be obtained from the website. TO FIND OUT MORE CIRCLE NO. 139
To be included in our next issue, send all your Business and Financial News stories to
heather@intlabmate.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
